Navigation Links
Antipsychotic Medications Cause Substantial Weight Gain in Children and Adolescents, According to Scientists at the Feinstein Institute for Medical Research and Zucker Hillside Hospital
Date:10/27/2009

ric Neuroscience. "Our findings suggest increased caution in prescribing them to pediatric patients."

The scientists studied 272 young people who had been prescribed antipsychotic medicines for a range of serious behavioral, mood and psychosis-related problems. The patients were prescribed one of a number of second-generation antipsychotics and followed over the first 12 weeks to assess changes in weight, blood glucose and lipids. At around 11 weeks, the young patients had gained an average of 19 pounds on the antipsychotic, olanzapine; 13.5 pounds on quetiapine; 11.9 pounds on risperidone; and 9.9 pounds on aripiprazole. By comparison, 15 patients who refused participation in the study or were not compliant with taking the antipsychotics were used as a control group and their weight gain during the same study period was less than a half-pound.

The findings were published this week in the Journal of the American Medical Association (JAMA).

The scientists also identified substantial changes in triglycerides and cholesterol, and found that the weight gain alone did not seem to explain entirely the adverse metabolic effects that varied significantly across the individual medications. All of the findings, Dr. Correll said, "should be considered when choosing antipsychotics." SATIETY (Second-Generation Antipsychotic Treatment Indications, Effectiveness and Tolerability in Youth) is the largest cohort study of atypical antipsychotic treatment in children and adolescents treated with antipsychotics. It is also the largest study of its kind in children or adults who received antipsychotic treatment for the first time in their life. This is a key study feature because prior treatment can obscure the true cardiometabolic effects of medications. In the SATIETY study, the antipsychotic-naïve youths suffered from a range of problems, including psychosis (30.1 percent,) mood disorders (47.8 percent) and aggressive behavior (22.1
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4 5

Related medicine news :

1. Antipsychotic Drugs Spur Dramatic Weight Gain in Kids
2. Mylan Receives FDA Approval for Additional Strengths of the Antipsychotic Haloperidol
3. FDA Panel OKs Newer Antipsychotics for Children
4. FDA Panel OKs Antipsychotic Seroquel for Children
5. FDA Panel Mulls Newer Antipsychotics for Kids
6. Joint Statement on Atypical Antipsychotic Use in Children
7. New tool to improve patient understanding of long-acting injectable antipsychotic therapies (LAT) unveiled in April issue of Psychiatry 2009
8. Newer Antipsychotics May Boost Weight in Alzheimers Patients
9. Combating weight gain caused by antipsychotic treatments
10. Newer Antipsychotics Pose Cardiac Risk: Study
11. Antipsychotics Up Death Risk in Alzheimers Patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Antipsychotic Medications Cause Substantial Weight Gain in Children and Adolescents, According to Scientists at the Feinstein Institute for Medical Research and Zucker Hillside Hospital 
(Date:3/5/2015)... As a result of the American ... Clearstream, LLC ’s products, services and company philosophies, ... products—led by their mPulse Hand Sanitizer—fits the core ... The AAPA—which represents a profession comprising than 100,000 ... specialties in the U.S.—advocates and educates on behalf ...
(Date:3/5/2015)... California (PRWEB) March 05, 2015 ... last week released a special issue ... the field of PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders ... Syndromes), an autoimmune reaction triggered by infections such ... which result in inflammation of the child's brain. ...
(Date:3/5/2015)... March 05, 2015 Wimbledon Health ... provides vascular, echocardiogram and NCV testing, announced ... the Chief Medical Officer. Dr. Artel will be responsible ... of the WimbledonMED program and the continued growth and ... about working with Wimbledon Health Partners as a consulting ...
(Date:3/5/2015)... March 5, 2015 – As National Patient Safety Awareness ... children’s hospitals around the country are affirming the critical ... safe as possible for their children. , A national ... Safety (SPS) and the Children’s Hospital Association—are collaborating to ... the hospital with their child. , “SPS is ...
(Date:3/5/2015)... The MTC 5-day Fundamental Implantology Course has ... a variety of dental disciplines, to offer implant placement ... the onset we wanted this course to be a ... the excellence of the lecturers and the sheer energy ... than satisfied our aims." , Unlike large-scale training ...
Breaking Medicine News(10 mins):Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 3Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 4Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 2Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 3Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 2Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 3Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 2Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 3Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 4Health News:MIS Global Training Center (MTC) Launches its Fundamental Implantology Course for Doctors - with a Difference 2
... Creates ... ... (Vocus) April 14, 2010 -- PMSI , one of the nation’s largest providers ... the nation’s leader in pain medication monitoring solutions, today announced a strategic partnership to ...
... in Alaska have discovered that lingering oil from the 1989 ... more than 20 years after the disaster. The research, published ... reveal long-term exposure to oil in harlequin ducks and demonstrates ... than years. The Exxon Valdez tanker ran aground on ...
... ... by HealthGrades, April 8, at the 2010 DTC National Conference. , ... Florham Park, N.J. (PRWEB) April 14, ... company for direct-to-consumer (DTC) marketing, today announced the winners of the 10th annual ...
... therapy, study found , WEDNESDAY, April 14 (HealthDay News) ... for developing blood clots, especially if they,re undergoing hormone ... it is important to consider thromboembolic [blood-clotting] side effects ... require endocrine treatment," said Mieke van Hemelrijck, lead author ...
... ... , ... 14, 2010 -- Tahitian Noni International (TNI) announced that just one month after ... have increased dramatically. Sales in North America have skyrocketed, and double digit growth was common ...
... ... Living Green and “Tip of the Day” at www.greenearthcleaning.com , featuring 365 easy ways ... ... environmentally friendly dry cleaning, GreenEarth Cleaning, LLC announced today the launch of a new feature ...
Cached Medicine News:Health News:PMSI and Ameritox Launch Program to Enhance Quality and Effectiveness of Opioid Therapy 2Health News:PMSI and Ameritox Launch Program to Enhance Quality and Effectiveness of Opioid Therapy 3Health News:Wildlife still exposed to Exxon Valdez oil 20 years after disaster 2Health News:2010 DTC National Advertising Award Winners Honored 2Health News:2010 DTC National Advertising Award Winners Honored 3Health News:Prostate Cancer Patients at Higher Risk of Blood Clots 2Health News:Prostate Cancer Patients at Higher Risk of Blood Clots 3Health News:Worldwide Sales in March Increase Dramatically At Tahitian Noni International 2Health News:GreenEarth Makes Every Day Earth Day with New Online Tools to Live a Greener Life 2Health News:GreenEarth Makes Every Day Earth Day with New Online Tools to Live a Greener Life 3
(Date:3/5/2015)... 5, 2015 Soligenix, Inc. (OTCQB: SNGX) (Soligenix ... to developing products that address unmet medical needs in ... that its President and Chief Executive Officer, Christopher ... at the 27 th Annual ROTH Conference in ... March 10, 2015 at 1:00 PM Pacific Daylight Time ...
(Date:3/5/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/5sqnn3/global_rising ) has ... Outlook 2015" report to their offering. ... after with fresh vigor as new targets , approaches ... to bring a paradigm change in the way diseases ... cell therapy/Regenerative Medicine space. The number of ...
(Date:3/5/2015)...  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a leading ... announced today that Atlanta -based Shepherd ... spinal cord injury and brain injury, has commenced enrollment ... progenitor cells) in newly injured patients with sensory and ... The Phase 1/2a trial follows the successful completion ...
Breaking Medicine Technology:Soligenix to Present at the 27th Annual ROTH Conference 2Soligenix to Present at the 27th Annual ROTH Conference 3Global Pharma Rising Stars Outlook 2015 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4
... April 10 Napo,Pharmaceuticals, Inc., (LSE: NAPL and ... a successfully completed Phase 2 trial for CRO-ID,(crofelemer ... conducted,by its partner, Glenmark Pharmaceuticals Limited (BSE: Glenmark). ... duration of diarrhea,stool frequency and stool consistency; additional ...
... Calif., April 10 MannKind,Corporation (Nasdaq: MNKD ... announcement by Pfizer Inc. that over the course ... patients treated with Exubera developed lung,cancer, although Pfizer ... whether this observation was related to Exubera. According ...
Cached Medicine Technology:Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea 2Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea 3Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea 4Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea 5MannKind Addresses Pfizer's Announcement Regarding Exubera 2MannKind Addresses Pfizer's Announcement Regarding Exubera 3
... Loading Units With Titanium Staples ... TA™ (Single Use Reloadable Stapler ... Auto Suture™ PREMIUM MULTIFIRE TA™ ... gynecological, pediatric and thoracic surgical ...
... Single Use Loading Units ... Series™ (Single Use Reloadable Staplers ... Auto Suture™ TA™ Reloadable staplers ... pediatric and thoracic surgical procedures ...
... Single Use reloadable linear stapler for resection, ... ,The Auto Suture™ MULTIFIRE GIA™ 60 and ... GIA™ 60 and 80 single use loading ... 60 knifeless single use surgical stapler with ...
... with titanium staples and in-line handle., ... use in the resection or transection of ... a double staggered row (or triple staggered ... of titanium staples and is available in ...
Medicine Products: